
Invectys
Operator of a biopharmaceutical company intended to offer an immunotherapy approach to treat cancer. The company focuses on mobilizing and restoring the anti-tumor capacity of the immune system of can...
Valuation
$0
Share Price
N/A
Total Raised
$83M
Last Round
N/A